中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2015年
2期
168-170
,共3页
陈晓佩%吴天凤%郑和昕%袁放%文晓林%谢海宝
陳曉珮%吳天鳳%鄭和昕%袁放%文曉林%謝海寶
진효패%오천봉%정화흔%원방%문효림%사해보
骨折%危险性评估%骨密度%糖尿病,2型
骨摺%危險性評估%骨密度%糖尿病,2型
골절%위험성평고%골밀도%당뇨병,2형
Fractures,bone%Risk assessment%Bone density%Diabetes mellitus,type 2
目的 探讨骨折风险评估工具(FRAX)对中老年2型糖尿病患者骨折风险的预测价值. 方法 对153例行骨密度检查的50岁以上2型糖尿病患者进行回顾性分析,根据FRAX指定的危险因子,记录研究对象的年龄、性别、身高、体质量、体质指数、既往脆性骨折史、父母髋部骨折史、当前吸烟史、过量饮酒史、长期使用类固醇激素史、风湿性关节炎、其他继发性骨质疏松症病史,及以股骨颈T值为代表的骨密度值(BMD);分别计算加入BMD的FRAX评分(FRAX/BMD)和不加入BMD的FRAX评分(FRAX/-).根据髋部脆性骨折风险≥3%或其他主要部位脆性骨折风险≥20%的治疗切点,分为治疗建议相同组和治疗建议不同组,应用独立t检验或卡方检验比较两组之间的危险因子. 结果 86.9%(133/153)患者不论是否加入BMD应用FRAX计算出的骨折风险相当,均能给出一致的治疗建议.年龄、性别和股骨颈T值在两组之间比较,差异有统计学意义(均P<0.001),其他危险因子两组差异无统计学意义. 结论 对于中老年2型糖尿病患者,FRAX/-对骨折风险的预测价值与FRAX/BMD基本相当,提示不进行骨密度检查也可预测骨折风险;年龄较小、骨密度值较大及男性对象的FRAX/-对骨折风险有更高的预测价值.
目的 探討骨摺風險評估工具(FRAX)對中老年2型糖尿病患者骨摺風險的預測價值. 方法 對153例行骨密度檢查的50歲以上2型糖尿病患者進行迴顧性分析,根據FRAX指定的危險因子,記錄研究對象的年齡、性彆、身高、體質量、體質指數、既往脆性骨摺史、父母髖部骨摺史、噹前吸煙史、過量飲酒史、長期使用類固醇激素史、風濕性關節炎、其他繼髮性骨質疏鬆癥病史,及以股骨頸T值為代錶的骨密度值(BMD);分彆計算加入BMD的FRAX評分(FRAX/BMD)和不加入BMD的FRAX評分(FRAX/-).根據髖部脆性骨摺風險≥3%或其他主要部位脆性骨摺風險≥20%的治療切點,分為治療建議相同組和治療建議不同組,應用獨立t檢驗或卡方檢驗比較兩組之間的危險因子. 結果 86.9%(133/153)患者不論是否加入BMD應用FRAX計算齣的骨摺風險相噹,均能給齣一緻的治療建議.年齡、性彆和股骨頸T值在兩組之間比較,差異有統計學意義(均P<0.001),其他危險因子兩組差異無統計學意義. 結論 對于中老年2型糖尿病患者,FRAX/-對骨摺風險的預測價值與FRAX/BMD基本相噹,提示不進行骨密度檢查也可預測骨摺風險;年齡較小、骨密度值較大及男性對象的FRAX/-對骨摺風險有更高的預測價值.
목적 탐토골절풍험평고공구(FRAX)대중노년2형당뇨병환자골절풍험적예측개치. 방법 대153례행골밀도검사적50세이상2형당뇨병환자진행회고성분석,근거FRAX지정적위험인자,기록연구대상적년령、성별、신고、체질량、체질지수、기왕취성골절사、부모관부골절사、당전흡연사、과량음주사、장기사용류고순격소사、풍습성관절염、기타계발성골질소송증병사,급이고골경T치위대표적골밀도치(BMD);분별계산가입BMD적FRAX평분(FRAX/BMD)화불가입BMD적FRAX평분(FRAX/-).근거관부취성골절풍험≥3%혹기타주요부위취성골절풍험≥20%적치료절점,분위치료건의상동조화치료건의불동조,응용독립t검험혹잡방검험비교량조지간적위험인자. 결과 86.9%(133/153)환자불론시부가입BMD응용FRAX계산출적골절풍험상당,균능급출일치적치료건의.년령、성별화고골경T치재량조지간비교,차이유통계학의의(균P<0.001),기타위험인자량조차이무통계학의의. 결론 대우중노년2형당뇨병환자,FRAX/-대골절풍험적예측개치여FRAX/BMD기본상당,제시불진행골밀도검사야가예측골절풍험;년령교소、골밀도치교대급남성대상적FRAX/-대골절풍험유경고적예측개치.
Objective To evaluate the predictive value of fracture risk assessment tool (FRAX) for determining fracture probabilities in middle-aged and elderly patients with type 2 diabetes.Methods Retrospective analysis was carried out on 153 type 2 diabetic patients aged over 50 years undergoing dual energy X-ray absorptiometry measurements.Fracture risk factors including age,gender,height,weight,body mass index,history of previous fragility fractures,parental history of hip fracture,history of smoking,excessive drinking,long-term use of steroid hormone,history of rheumatoid arthritis,the history of secondary osteoporosis diseases,and femoral neck T-score of bone mineral density (BMD) were recorded.FRAX scores with BMD (FRAX/BMD) and without BMD (FRAX/-) were calculated.Therapeutic interventions were recommended if the 10-year risk of fractures was more than 3% for hip osteoporotic fractures and more than 20% for other major fractures.Subjects were separated into the identical treatment recommendation group and the different treatment recommendation.Fracture risk factors were compared between groups.Results 133 (6.9 %) patients had identical fracture risk predictions in the FRAX calculation,regardless of whether BMD join in or not.Age,gender and femoral neck T scores had significant differences between the two groups (all P<0.001),while other risk factors had no statistical differences between the two groups (all P>0.05).Conclusions In most middle-aged and elderly patients with type 2 diabetes,the FRAX/-provides the same prediction as FRAX/BMD value for predicting fracture risk,which shows that fracture risks can be predicted without bone density examination.The FRAX/-has higher predictive values on fracture for people who are younger,male,and has higher BMD.